Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "UAE Pharmaceuticals Market, By Region, Competition, Forecast and Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's offering.
The UAE Pharmaceuticals Market is poised for impressive growth between 2019 and 2029, buoyed by a combination of demographic shifts, increased healthcare spending, and government initiatives. Valued at USD 4.38 billion in 2023, the market's robust growth trajectory is set to continue as it rides high on the country's focus on healthcare infrastructure, a growing population, and strategic positioning as a leading pharmaceutical hub in the Middle East and Africa.
Driving Factors
Several core aspects are underpinning the expansion of the UAE Pharmaceuticals Market. A growing population and rising prevalence of chronic diseases are central to the increased demand for pharmaceutical products. Similarly, strategic geographic location and a cutting-edge logistics infrastructure are greatly enabling trade and distribution networks within the region. The government's decisive push towards healthcare innovation and substantial investment in healthcare infrastructure are pivotal in fostering a fertile landscape for medical advances and pharmaceutical development.
Market Dynamics
The market is undergoing transformations driven by the prevalence of chronic diseases, increased healthcare expenditure, and the strategic geographic location of the UAE. Increased patient demand, especially from medical tourism, and digital health innovations continue to present valuable opportunities for market players. Nonetheless, the sector also faces challenges such as the need to navigate intellectual property issues and respond to supply chain volatilities. Businesses operating within this market are expected to adapt to these dynamics to maximize growth and remain competitive.
Segmental Insights
A detailed analysis of the market reveals significant growth across multiple segments, including generic drugs and Over-The-Counter (OTC) medications. While generic drugs are favored for their cost-effectiveness, OTC products maintain their lead due to accessibility and consumer empowerment. Moreover, the strategic importance of hubs like Dubai cannot be overstated, with critical infrastructural and regulatory advantages driving the pharmaceutical sector forward in the UAE.
Leading Market Players
The market landscape features an array of established companies, with key players like Pfizer Gulf FZ-LLC and Julphar (Gulf Pharmaceutical Industries) at the helm. These entities contribute to the sector with a diverse range of pharmaceutical products, holding substantial influence over market trends and directional growth.
In summary, the UAE Pharmaceuticals Market stands as a beacon of growth and innovation, with the next decade likely to witness its continued ascendancy in the regional and global pharmaceutical arena.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 80 |
| Forecast Period | 2023 - 2029 |
| Estimated Market Value (USD) in 2023 | $4.38 billion |
| Forecasted Market Value (USD) by 2029 | $6.87 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | United Arab Emirates |
A selection of companies mentioned in this report includes, but is not limited to:
- Pfizer Gulf FZ-LLC
- Julphar (Gulf Pharmaceutical Industries)
- Roche Pharmaceutical Middle East FZCO
- Niner Pharmaceuticals LLC
- Lifepharma FZE
- Hikma UAE
- Al Hayat Pharmaceuticals
- Modern Pharmaceutical Company LLC
- ADCAN Pharma
- Globalpharma Co. (L.L.C.)
For more information about this report visit https://www.researchandmarkets.com/r/dijmoq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
